WATCH ALL SESSIONS NOW
All sessions were recorded at the International Symposium on Malignant Mesothelioma at the Notary Hotel in Philadelphia from October 25-26, 2025.
Click below to watch each session.
How mesothelioma patients can utilize integrative medicine
Nutrition and mesothelioma
Pleural Tumor Board Panel
Legal Panel
Imaging in the Future with AI
What’s New in Clinical Trials
Pathways to Advocacy
Caregiver Study in collaboration with Michigan State University
Peritoneal Tumor Board Panel
Patient Survivorship Panel
Maintaining Emotional Balance
Patient Clinical Trials Panel
PHOTOS FROM THE 2025 SYMPOSIUM
THANK YOU TO OUR SPONSORS
WATCH ALL SESSIONS NOW
The Meso Foundation’s International Symposium on Malignant Mesothelioma is a unique conference that brings together the entire mesothelioma community. We invite patients, their families, caregivers, and the bereaved community, to learn about the latest in treatment options, speak face-to-face with top mesothelioma experts, and find community and support with others walking in their shoes.
WHO SHOULD ATTEND
- Patients, their families, caregivers, friends
- Those who have lost a loved one to mesothelioma
- Anyone else interested in making a difference
AGENDA HIGHLIGHTS
- Sessions on nutrition, integrative medicine, and mental health during a cancer diagnosis and treatment
- Expert panels on pleural and peritoneal mesothelioma
- Awards dinner acknowledging individuals who are making strides in the mesothelioma community
- What’s new in clinical trials
- Community social dinner cruise
- Sessions and conversations that include the role of genetics, patient perspectives on clinical trials, and what survivorship looks like
- Support groups
- Celebration of life
CONFERENCE CENTER
Notary Hotel
Grand Ballroom
21 N Juniper St.
Philadelphia, PA 19107
THE NOTARY HOTEL
We have secured a room block at the Notary Hotel for a $299/night rate.
The last day to guarantee this pricing is September 25th.
SPEAKERS
The following speakers have been confirmed as of June 20. This list is subject to change.
Mehmet Altan, MD, MD Anderson Cancer Center
Andrew Blakely, MD, National Institutes of Health
Kevin Blyth, MD, University of Glasgow
Adam Bograd, MD, Swedish Health Services
Dean Fennell, FRCP, PhD, University of Leicester
Beth Flanzbaum, LICSW
Jason Foster, MD, University of Nebraska
Georgios Karagkounis, MD, Memorial Sloan Kettering Cancer Center
Jennifer Keller, MSS, LCSW, OSW-C, Fox Chase Cancer Center
Hedy Kindler, MD, University of Chicago Medicine
Alexandra Lebensohn, MS, CGC, National Institutes of Health
Melina Marmarelis, MD, Penn Medicine
Santhosshi Narayanan, MD, MD Anderson Cancer Center
Michael Offin, MD, Memorial Sloan Kettering Cancer Center
Taylor Ripley, MD, Baylor
Carly Roop, RD, CSO, MA UPenn
Marjorie G. Zauderer, MD, Westchester Medical Center Health Network